Facebook
Twitter
Telegram
Fehler meldenEnveric Biosciences Finanzdaten 2011-2024 | ENVB
Jahresabschluß Enveric Biosciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
2.36 M | 300 K | 1.97 M | - | - | - | - | - | - | - | - | - |
Anteile |
1.45 M | 472 K | 532 K | - | - | - | - | - | - | - | - | - |
Kurshistorie |
1.63 | 0.636 | 3.7 | 5.24 | 23 | 255 | 651 | 602 | - | - | - | - |
Nettogewinn |
-18.5 M | -49 M | -6.86 M | -5.6 M | -16.9 M | -9.07 M | -2.78 M | -1.89 M | -33.6 K | -161 | -24.6 K | -33.4 K |
Umsatz |
- | - | - | 39.9 M | 43 M | 48.6 M | 36.1 M | 16 M | - | - | - | - |
Umsatzkosten |
- | - | - | 31.8 M | 34 M | 38.4 M | 29.6 M | 13.4 M | 5.23 M | - | - | - |
Bruttoertrag |
- | - | - | 8.15 M | 8.98 M | 10.2 M | 6.54 M | 5.75 M | - | - | - | - |
Betriebsergebnis |
-27.4 M | -64.6 M | -5.62 M | -2.3 M | -7.15 M | -10.9 M | -5.38 M | -794 K | 32.8 K | 27.2 K | -22.7 K | -31.4 K |
Zinsaufwendungen |
5.25 K | 10.3 K | 445 K | 81.8 K | 730 K | 575 K | 751 K | 238 K | 15 | - | - | - |
EBITDA |
-27.1 M | -64 M | -6.3 M | -4.06 M | -1.81 M | -8.27 M | -2.43 M | -56.8 K | -32.8 K | -27.2 K | -22.7 K | -31.4 K |
Betriebsaufwand |
- | - | 5.62 M | 14.5 M | 13.7 M | 21.7 M | 10.3 M | 5.97 M | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
11.6 M | 20.5 M | 5.44 M | - | - | - | 8.55 M | 5.69 M | 32.8 K | 27.2 K | 22.7 K | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Enveric Biosciences
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
2.16 M | 2.11 M | 2.08 M | 2.08 M | 1.79 M | 1.05 M | 847 K | 652 K | 459 K | 427 K | 16.2 M | 10.1 M | 5.29 M | 3.52 M | 5.65 M | 5.31 M | 2.11 M | 2.03 M | 1.81 M | 1.69 M | 21.7 M | 18.8 M | 18.7 M | 18.2 M | 14.7 M | 14.6 M | 14.1 M | 13.9 M | 13.7 M | 12.8 M | 11.9 M | 11.9 M | 9.99 M | 11.6 M | 9.99 M | 15.4 M | 15.4 M | 9.99 M | 9.99 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 8.48 M | 6.5 M | 6.5 M |
Nettogewinn |
-2.82 M | -6.36 M | -4.68 M | - | -2.48 M | -2.79 M | -4.52 M | - | -2.71 M | -908 K | -3.25 M | - | -565 K | -818 K | -1.1 M | - | -5.61 M | -5.61 M | -1.86 M | - | 5.7 M | -1.26 M | -1.57 M | - | -4.07 M | -3.28 M | -722 K | - | -1.78 M | -1.21 M | -1.16 M | - | -160 K | 111 K | 1.08 M | - | -3.18 K | 408 K | 408 K | - | -4.56 K | -3.89 K | -4.7 K | - | -4.87 K | -4.08 K | -4.04 K | - | -3.69 K | -3.63 K | -11.1 K |
Umsatz |
- | - | - | - | - | - | - | - | - | - | - | - | 8.48 M | 8.25 M | 9.6 M | - | 9.15 M | 11 M | 10.7 M | - | 10.6 M | 11.1 M | 11.1 M | - | 12.5 M | 12.3 M | 12.3 M | - | 10.1 M | 6.69 M | 7.01 M | - | 4.46 M | 3.93 M | 4.28 M | - | - | 3.99 M | 3.99 M | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | 6.6 M | 6.44 M | 7.72 M | - | 7.25 M | 8.63 M | 8.55 M | - | 8.23 M | 8.69 M | 8.72 M | - | 9.97 M | 9.94 M | 9.04 M | - | 8.36 M | 5.17 M | 5.37 M | - | 3.02 M | 2.95 M | 3.17 M | - | - | 2.91 M | 2.91 M | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | 1.89 M | 1.82 M | 1.88 M | - | 1.9 M | 2.38 M | 2.14 M | - | 2.35 M | 2.39 M | 2.34 M | - | 2.56 M | 2.33 M | 3.3 M | - | 1.7 M | 1.52 M | 1.65 M | - | 1.44 M | 983 K | 1.12 M | - | - | 1.08 M | 1.08 M | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-3.45 M | -5.76 M | -4.86 M | - | -5.66 M | -4.71 M | -4.8 M | - | -3.52 M | -3.36 M | -6.76 M | - | -490 K | -768 K | -837 K | - | -1.56 M | -1.48 M | -1.3 M | - | 6.1 M | -1.08 M | -1.37 M | - | -3.95 M | -3.51 M | -631 K | - | -1.29 M | -937 K | -981 K | - | -316 K | 180 K | 1.08 M | - | -3.11 K | 575 K | 575 K | - | -4.56 K | -3.89 K | -4.7 K | - | -4.57 K | -4.08 K | -4.04 K | - | -3.69 K | -3.63 K | -11.1 K |
Zinsaufwendungen |
2.24 K | 916 | 11 | - | -308 | -668 | 4.14 K | - | 370 | 4.82 K | - | - | 75.5 K | 50.9 K | 262 K | - | 695 K | 695 K | 143 K | - | 190 K | 183 K | 211 K | - | 133 K | 164 K | 90.8 K | - | 290 K | 271 K | 114 K | - | 62.1 K | 25.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-3.36 M | -5.67 M | -4.77 M | - | -5.57 M | -4.62 M | -4.73 M | - | -3.34 M | -3.19 M | -6.63 M | - | 66.5 K | -234 K | -277 K | - | -1 M | -914 K | -737 K | - | 6.74 M | -270 K | -546 K | - | -3.13 M | -2.68 M | 58.6 K | - | -782 K | -835 K | -870 K | - | -306 K | 188 K | 1.08 M | - | -3.11 K | 584 K | 584 K | - | -4.56 K | -3.89 K | -4.7 K | - | -4.57 K | -4.08 K | -4.04 K | - | -3.69 K | -3.63 K | -11.1 K |
Betriebsaufwand |
- | - | - | - | - | - | - | - | - | - | - | - | 3.01 M | 3 M | 3.48 M | - | 3.46 M | 3.86 M | 3.44 M | - | -3.75 M | 3.47 M | 3.71 M | - | 6.51 M | 5.84 M | 3.93 M | - | 2.99 M | 2.45 M | 2.63 M | - | 1.76 M | 803 K | 42 K | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.69 K | 3.63 K | - |
Allgemeine und Verwaltungsausgaben |
2.01 M | 3.16 M | 2.78 M | - | 3.51 M | 2.5 M | 2.77 M | - | 2.12 M | 2.31 M | 6.47 M | - | 427 K | 717 K | 837 K | - | 2.9 M | 3.3 M | 2.88 M | - | 2.66 M | 2.52 M | 2.88 M | - | 5.28 M | 4.41 M | 2.7 M | - | 1.33 M | 1.98 M | 2.11 M | - | 1.5 M | 490 K | 33.7 K | - | 3.11 K | 505 K | 505 K | - | 4.56 K | 3.89 K | 4.7 K | - | 4.57 K | 4.08 K | 4.04 K | - | 3.69 K | 3.63 K | 11.1 K |
Alle Zahlen in USD-Währung